HTC Corp (宏達電) yesterday said it is to sell a plot of land and a building in Taoyuan to Inventec Corp (英業達) for NT$6.06 billion (US$183.46 million) as part of its efforts to lower operational costs and boost efficiency.
The local smartphone maker said the production facilities and its employees would be transferred to HTC’s three other properties in Taoyuan to centralize its production facilities.
“The sale of the land and building will not affect HTC’s production capacity or shipping schedules,” an HTC investor relations officer said by telephone.
The officer said the transaction also has no implications for HTC’s operations or headcount.
After deducting transaction costs and tax payments, the firm is to book a NT$2.1 billion non-operating gain from the sale of the land and the building, the smartphone company said.
“A non-operating gain of NT$2.1 billion is to be booked in the first quarter of next year,” the officer said.
When asked whether HTC has plans to sell other assets to continue to cut its operating costs, the company said it would review all the possibilities based on its operational needs.
The smartphone maker reported a net loss of NT$12.56 billion in the first three quarters of this year, a significant decline from a net profit of NT$1.01 billion in the same period last year.
That represented a loss per share of NT$14.68 from January to September, compared with earnings per share of NT$1.23 last year.
In the quarter ending Sept. 30, HTC had NT$43.3 billion in cash and cash equivalents, its balance sheet showed.
In an attempt to meet the expanding scale of its server business, Inventec said its board of directors approved the NT$6.06 billion purchase of the land and building from HTC.
“The building will be used as the main office of Inventec’s server business,” an Inventec investor relations officer said by telephone.
The officer said Inventec’s server business is based in two offices in Taoyuan and the purchase of the building from HTC would help the company centralize the management of its server business.
The officer said the firm also plans to set up a research and development center for the server business in the building.
Inventec said it expects the transaction to complete in March next year and it expects to transfer the server business and its employees to the building in the second quarter of next year.
The NT$6.06 billion transaction costs would be booked in the first quarter of next year, the firm said.
After moving the server business to the new building, the remaining offices in Taoyuan would be used for Inventec’s solar business, the officer said.
HTC shares rose 0.63 percent to close at NT$79.5 in Taipei trading yesterday, while Inventec shares remained unchanged at NT$21.9. The TAIEX lost 0.77 percent.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS